ACTRN12619001383156
Completed
Phase 1
Pilot trial assessment of the diagnostic value of Cu64 SAR-Bombesin PET/CT imaging for staging of ER/PR + HER2- breast cancer patients with metastatic disease in comparison with conventional imaging (CT, bone scan and 18F-FDG PET/CT)
St Vincent's Hospital0 sites7 target enrollmentOctober 10, 2019
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hormone Positive Metastatic Breast Cancer
- Sponsor
- St Vincent's Hospital
- Enrollment
- 7
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ability to provide informed consent documentation indicating that they understand the purpose of and procedures required for the study, and are willing to participate in the study
- •Female patients aged 18 or above with ER/PR \+ve metastatic breast cancer being restaged prior to treatment of metastatic disease.
- •Have a 12 lead ECG recording on their first visit showing the following,
- •Heart rate between 45 and 100 beats per minute
- •Corrected QT interval of less than or equal to 450ms
- •No clinically significant abnormalities including morphology (Eg, left bundle branch block, atrioventricular nodal dysfunction, ST segment abnormalities)
Exclusion Criteria
- •Pregnancy or lactation
- •Significant inter\-current acute illness including (but not limited to) requiring the use of intravenous antibiotics, illness associated with any signs of haemodynamic instability, or illness as determined by trial investigators that warrant other emergent treatment
- •ECOG status higher than 2
- •History of significant renal (CKD grade 2 or above) or hepatic disease (MELD score of 1 or above)
- •Major surgery (any procedure requiring general anaesthesia) in 6 weeks prior to visit 1
- •Use of immunosuppresants or known immunosuppressed state
- •History of cancers other than breast cancer
- •Clinically significant abnormal values for safety laboratory tests (haematology, biochemistry or urinalysis) or vital signs at visit 1
- •Any other reason that the investigator considers makes the patient unsuitable to participate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
Can blocking the nerve to the back muscle predict the outcome of stimulating back muscles in managing pain due to muscle dysfunction?Low back painChronic low back painMusculoskeletal DiseasesISRCTN12101415eeds Teaching Hospitals NHS Trust45
Recruiting
N/A
Pilot study of 68Ga-Pentixafor positron emission tomography (PET) imaging in multiple myelomaACTRN12617000593336Royal Brisbane and Women's Hospital10
Completed
N/A
The clinical pilot study for the evaluation of the efficacy and safety of Monascus-fermentation (Monascus-fermented black bean) on reducing body weight and serum total cholesterol obese subjectsKCT0001040Inje University Seoul Paik Hospital30
Completed
Phase 1
The behavior intervention on control of glucose among diabetic patientsIRCT20111119008132N7Tabriz University of Medical Sciences90
Not Yet Recruiting
N/A
To Study Whether Pain at a point behind and below The Ear Indicates Eustachian Tube BlockadeHealth Condition 1: H681- Obstruction of Eustachian tubeCTRI/2021/09/036817Karnataka Institute of Medical Sciences